Bausch Health Companies (BHC) Cash from Financing Activities (2009 - 2026)

Bausch Health Companies has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$100.0 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$100.0 million, up 31.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$696.0 million (down 3.26% YoY), and the FY2025 annual result was -$742.0 million, up 14.52% from the prior year.
• Cash from Financing Activities came in at -$100.0 million for Q1 2026 at Bausch Health Companies, up from -$235.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.8 billion in Q3 2023 to a low of -$719.0 million in Q3 2025.
• The 5-year median for Cash from Financing Activities is -$142.0 million (2023), against an average of -$41.7 million.
• Across the five-year window, Cash from Financing Activities soared 5144.44% in 2023 and slumped 376.47% in 2025, its largest moves.
• Bausch Health Companies' Cash from Financing Activities stood at -$276.0 million in 2022, then surged by 71.38% to -$79.0 million in 2023, then soared by 207.59% to $85.0 million in 2024, then plunged by 376.47% to -$235.0 million in 2025, then soared by 57.45% to -$100.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$100.0 million (Q1 2026), -$235.0 million (Q4 2025), and -$719.0 million (Q3 2025), per Business Quant data.